Friday, September 10, 2010

Rethinking Drug Development: Open Source Approaches has just published a 90-minute presentation on Open Source Drug Development, part of the Open Science Summit.  I found all the addresses fascinating and I recommend that you listen to the segments by each of the presenters, as well as to the Q&A.  If, however, you don't have the time then listen to this clip, the last four minutes of the Q&A session.  The speaker is (mainly) Andrew Hessel, who talked about Pink Army Cooperative, an Open Source biotechnology venture working to create individualized therapies for breast cancer using breakthroughs in what has come to be called synthetic biology.  It is an extraordinary new approach, the exact opposite of the "one-size-fits-all", blockbuster drug cure usually pursued by "Big Pharma" and it should prove applicable beyond the domain of breast cancer.  To get an idea of how revolutionary this approach could be just listen to this clip.


No comments: